Integrated Advisors Network’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Hold |
20,603
| – | – | ﹤0.01% | 735 |
|
|
2025
Q1 | $109K | Buy |
20,603
+3,015
| +17% | +$15.9K | 0.01% | 693 |
|
|
2024
Q4 | $119K | Buy |
17,588
+4,731
| +37% | +$32K | 0.01% | 681 |
|
|
2024
Q3 | $84.7K | Sell |
12,857
-1,070
| -8% | -$7.05K | ﹤0.01% | 685 |
|
|
2024
Q2 | $104K | Buy |
13,927
+1,141
| +9% | +$8.56K | 0.01% | 665 |
|
|
2024
Q1 | $127K | Buy |
+12,786
| New | +$127K | 0.01% | 679 |
|